Related Experiment Video

Updated: Mar 9, 2026

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

13.9K

Estradiol shows anti-skin cancer activities through decreasing MDM2 expression

Li Li1, Jianguo Feng1,2, Ying Chen1

  • 1Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing, China.

Oncotarget
|December 31, 2016
PubMed

Insights

Estradiol, a hormone, inhibits skin cancer by increasing hnRNPA1 and decreasing MDM2 oncogene expression, suppressing tumor growth and preventing carcinogenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Endocrinology

Background:

  • Estradiol's role in cancer is complex and not fully understood.
  • Heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) interacts with MDM2, an oncogene overexpressed in cancers.

Purpose of the Study:

  • To investigate the correlation between estradiol, hnRNPA1, and MDM2 in cancer cell behavior.
  • To elucidate the mechanism of estradiol's effect on melanoma.

Main Methods:

  • Cell culture experiments with estradiol treatment and hnRNPA1 siRNA.
  • Analysis of hnRNPA1 and MDM2 expression at protein and gene levels.
  • In vivo studies involving subcutaneous tumor injection and estradiol administration.

Main Results:

  • Estradiol (10×10-13M) increased hnRNPA1 expression and decreased MDM2 expression, inhibiting cell proliferation, migration, and epithelial-mesenchymal transition.
  • Knocking down hnRNPA1 increased MDM2 expression.
  • In vivo, estradiol suppressed tumor growth and reduced MDM2 expression.

Conclusions:

  • Estradiol exerts anti-cancer effects by upregulating hnRNPA1, which subsequently downregulates MDM2.
  • This mechanism highlights a novel therapeutic strategy for estradiol in combating skin cancer.
Keywords:
MDM2estradiolhnRNPA1melanomastherapeutic

More Related Videos

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.4K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K